Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...
CDSCO Warns Against Stolen Novo Nordisk Batches during Transit: Nationwide Alert on Insulin & Semaglutide Injections
PharmaGenDRx News Bureau- 22nd August,2025
03:00 PM IST
The Central Drugs...